Home Cart Sign in  
Chemical Structure| 145459-19-4 Chemical Structure| 145459-19-4

Structure of Heterophyllin B
CAS No.: 145459-19-4

Chemical Structure| 145459-19-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Heterophyllin B is an active cyclic peptide isolated from the heterophylla of Pseudostellaria. Heterophyllin B can be used in the study of esophageal cancer.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Heterophyllin B

CAS No. :145459-19-4
Formula : C40H58N8O8
M.W : 778.94
SMILES Code : O=C(N1[C@](CCC1)([H])C(N2[C@](CCC2)([H])C(N3[C@](CCC3)([H])C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC4=CC=CC=C4)C(NCC(NC5)=O)=O)=O)=O)=O)=O)[C@H](CC(C)C)NC5=O
MDL No. :MFCD22125018
InChI Key :KYAVLJJQNUHRMR-PPLFBOPFSA-N
Pubchem ID :102022989

Safety of Heterophyllin B

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Related Pathways of Heterophyllin B

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW 264.7 macrophages 50, 100 μM 30 minutes To evaluate the effect of HB on LPS-induced PI3K and AKT phosphorylation, results showed HB up-regulated the relative ratio of p-AKT/AKT and p-PI3K/PI3K. Molecules. 2018 Mar 21;23(4):717
RAW 264.7 macrophages 50, 100 μM 18 hours To evaluate the effect of HB on LPS-induced IL-6 and IL-1β mRNA expression, results showed HB suppressed the mRNA expression of these cytokines. Molecules. 2018 Mar 21;23(4):717
RAW 264.7 macrophages 100 μM 18 hours To evaluate the effect of HB on LPS-induced apoptosis, results showed HB inhibited apoptosis of RAW 264.7 cells. Molecules. 2018 Mar 21;23(4):717
RAW 264.7 macrophages 100 μM 18 hours To evaluate the effect of HB on LPS-induced ROS production, results showed HB effectively attenuated ROS generation. Molecules. 2018 Mar 21;23(4):717
RAW 264.7 macrophages 25, 50, 100 μM 18 hours To evaluate the effect of HB on LPS-induced IL-6 and IL-1β production, results showed HB significantly reduced cytokine production. Molecules. 2018 Mar 21;23(4):717
RAW 264.7 macrophages 25, 50, 100 μM 18 hours To evaluate the effect of HB on LPS-induced NO production, results showed HB reduced NO production in a dose-dependent manner. Molecules. 2018 Mar 21;23(4):717
RAW 264.7 macrophages 25, 50, 100 μM 24 hours To evaluate the effect of HB on cell viability, results showed no cytotoxicity at concentrations ranging from 0-100 μM. Molecules. 2018 Mar 21;23(4):717
ECA-109 human esophageal carcinoma cells 0, 10, 25, 50 µM 24 hours HB significantly suppressed the adhesion and invasion of ECA-109 cells in a dose-dependent manner. Mol Med Rep. 2016 Feb;13(2):1097-104

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice Spinal cord injury model Intraperitoneal injection 20 mg/kg Once daily for three days Evaluate the effect of Heterophyllin B on functional recovery after spinal cord injury, results showed that Heterophyllin B significantly promotes functional recovery Int J Biol Sci. 2024 Oct 7;20(14):5415-5435

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.28mL

0.26mL

0.13mL

6.42mL

1.28mL

0.64mL

12.84mL

2.57mL

1.28mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories